| Factor XII promotes blood coagulation independent of factor XI in the presence of long‐chain polyphosphates C Puy, EI Tucker, ZC Wong, D Gailani, SA Smith, SH Choi, JH Morrissey, ... Journal of thrombosis and haemostasis 11 (7), 1341-1352, 2013 | 116 | 2013 |
| DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant LW Dillon, G Gui, KM Page, N Ravindra, ZC Wong, G Andrew, ... JAMA 329 (9), 745-755, 2023 | 93 | 2023 |
| The bacterial virulence factor CagA induces microbial dysbiosis that contributes to excessive epithelial cell proliferation in the Drosophila gut TA Jones, DZ Hernandez, ZC Wong, AM Wandler, K Guillemin PLoS pathogens 13 (10), e1006631, 2017 | 50 | 2017 |
| Prenatal exposure to pesticides and risk for holoprosencephaly: a case-control study YA Addissie, P Kruszka, A Troia, ZC Wong, JL Everson, BA Kozel, ... Environmental Health 19 (1), 1-13, 2020 | 40 | 2020 |
| Identifying environmental risk factors and gene–environment interactions in holoprosencephaly YA Addissie, A Troia, ZC Wong, JL Everson, BA Kozel, M Muenke, ... Birth Defects Research 113 (1), 63-76, 2021 | 26 | 2021 |
| Social, neurodevelopmental, endocrine, and head size differences associated with atypical deletions in Williams–Beuren syndrome M Lugo, ZC Wong, CJ Billington Jr, PCR Parrish, G Muldoon, D Liu, ... American Journal of Medical Genetics Part A 182 (5), 1008-1020, 2020 | 22 | 2020 |
| Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia LW Dillon, G Gui, N Ravindra, G Andrew, D Mukherjee, ZC Wong, ... JAMA oncology, 2024 | 21 | 2024 |
| Generating human bone marrow organoids for disease modeling and drug discovery AA Olijnik, A Rodriguez-Romera, ZC Wong, Y Shen, JS Reyat, NJ Jooss, ... Nature Protocols, 1-30, 2024 | 18 | 2024 |
| Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in … CS Hourigan, LW Dillon, G Gui, N Ravindra, Z Wong, G Andrew, ... Journal of clinical oncology 40 (16_suppl), 7006-7006, 2022 | 10 | 2022 |
| A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin 1 axis R Li, M Colombo, G Wang, A Rodriguez-Romera, J O'Sullivan, SA Clark, ... bioRxiv, 2023.08. 05.550630, 2023 | 8 | 2023 |
| Measurable residual disease in patients undergoing allogeneic transplant for acute myeloid leukemia ZC Wong, LW Dillon, CS Hourigan Best Practice & Research Clinical Haematology, 101468, 2023 | 7 | 2023 |
| Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia G Gui, N Ravindra, PS Hegde, G Andrew, D Mukherjee, Z Wong, ... Bone marrow transplantation, 1-10, 2024 | 4* | 2024 |
| Development of a First-in-Class CAR-T Therapy Against Calreticulin-Mutant Neoplasms and Evaluation in the Relevant Human Tissue Environment A Rampotas, Z Wong, I Gannon, C Benlabiod, Y Shen, C Brierley, ... Blood 144, 871, 2024 | 1 | 2024 |
| Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia PS Hegde, G Andrew, G Gui, N Ravindra, D Mukherjee, ZC Wong, ... Bone Marrow Transplantation, 1-3, 2024 | 1 | 2024 |
| Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams–Beuren Syndrome D Liu, CJ Billington Jr, N Raja, ZC Wong, MD Levin, W Resch, C Alba, ... Journal of the American Heart Association, e031377, 2024 | 1 | 2024 |
| Pre-MEASURE: FLT3-ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission LW Dillon, G Gui, N Ravindra, Z Wong, G Andrew, D Mukherjee, SZ Zeger, ... medRxiv, 2022.10. 21.22281322, 2022 | 1 | 2022 |
| FXII promotes coagulation in a FXI and FIX independent manner C Puy, ZC Wong, EI Tucker, A Gruber, D Gailani, SA Smith, SH Choi, ... Blood 120 (21), 3362, 2012 | 1 | 2012 |
| The Road Less Traveled: T Cell-Engaging Immunotherapies for Myeloid Malignancies ZC Wong, B Psaila The Hematologist 22 (1), eadl4492, 2025 | | 2025 |
| Abstract C049: Implementing human bone marrow organoids to interrogate microenvironmental influences on the efficacy of blood cancer immunotherapies ZC Wong, Y Shen, A Rampotas, I Gannon, C Brierley, C Benlabiod, ... Cancer Research 84 (22_Supplement), C049-C049, 2024 | | 2024 |
| Measurable Residual Mutated NPM1 before Allogeneic Transplant for Acute Myeloid Leukemia RW Al-Ali, G Gui, N Ravindra, G Andrew, D Mukherjee, Z Wong, Y Huang, ... Blood 144, 2950, 2024 | | 2024 |